An exploratory mediation analysis of the effects on kidney outcomes (composite of macroalbuminuria, decreased GFR, renal death) with liraglutide and semaglutide in patients with T2DM in the LEADER and SUSTAIN-6 trials observed that HbA1c mediated 2526% and SBP 922% of kidney effects with a negligible contribution of the other parameters studied, such as body weight [15]
Common Areas Where Patients Notice Skin Changes Face and Neck One of the most noticeable areas affected by weight loss is the face
New data suggests GLP-1 medications may also change how people spend their money
DOI: Published online: February 14, 2024 1 Borthwick Diabetes Research Centre, Lister Hospital, Stevenage, UK 2 Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland Corresponding author: Adie Viljoen
If you need to remove sensitive foods from your diet, visit Thrive Market to get food alternative ideas